RxDoctor Payments Data

Melanie Palm, MD

Dermatology · Solana Beach, CANPI 1821265877

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $336,615 of the $519,969 with a category attached, or 64.7%. Galderma Laboratories, L.p. accounts for 62.4% of it on its own, with 14 other manufacturers making up the rest. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$519,969in general payments, 2019–2025

Across 480 payments — averaging $1083.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$324K
  • AbbVie$122K
  • Merz North America, Inc.$44K
  • Lumenis Ltd.$25K
  • Lumenis, Inc$3K
  • Endo Pharmaceuticals Inc.$461
  • plus $1K from 9 others
$1,651,257in research payments, 2019–2025

Across 249 payments — averaging $6631.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$1.3M
  • Endo Pharmaceuticals Inc.$205K
  • Merz North America, Inc.$188K
  • Galderma Laboratories, L.p.$4K

What the payments were for

  • Consulting fees$336,61565%
  • Speaking & faculty fees$152,11629%
  • Travel & lodging$20,2554%
  • Food & beverage$10,9412%
  • Education$420%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$519,969 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Medicare billing

Part B allowed, 2024
$178,823
Medicare patients
299
Services billed
2,718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Imiquimod30$1,116
ValacyclovirValacyclovir Hcl29$783
Doxycycline Hyclate32$582
Mometasone Furoate15$256
Ketoconazole11$115

Paid to pharmacies, not to this prescriber.

Other dermatology in Solana Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →